A prospective study: Evaluation of the antibody-dependent cell-mediated cytotoxicity assay in Chronic active Epstein-Barr syndrome

N. Waters-Peacocke, Betty Beasley Wray, E. W. Ades

Research output: Contribution to journalArticle

1 Scopus citations


Prospective monitoring of active Chronic Epstein-Barr virally infected patients receiving gammaglobulin therapy was performed using the antibody-dependent cell-mediated cytotoxicity assay (ADCC). Efforts were made to analyze and define with respect to clinical course the autologous immunological parameters (cells and sera). Our data demonstrate that the diagnosis and clinical course of this syndrome proved inconsistent with the assays usefulness in predicting suggestive benefits of gammaglobulin therapy.

Original languageEnglish (US)
Pages (from-to)11-12
Number of pages2
JournalJournal of Clinical and Laboratory Immunology
Issue number1
StatePublished - Dec 1 1988


ASJC Scopus subject areas

  • Immunology

Cite this